文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[Safety and efficacy of chimeric antigen receptor T cell in the treatment of elderly patients with hematological malignancies].

作者信息

Liu D, Ke P, Huo L, Hu X H, Fu C C, Li C X, Huang H W, Xue S L, Qiu H Y, Wu D P, Ma X

机构信息

The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Suzhou 215006, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2018 Nov 14;39(11):952-955. doi: 10.3760/cma.j.issn.0253-2727.2018.11.017.

DOI:10.3760/cma.j.issn.0253-2727.2018.11.017
PMID:30486596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7342352/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ec/7342352/4befc2315ddd/cjh-39-11-952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ec/7342352/4befc2315ddd/cjh-39-11-952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ec/7342352/4befc2315ddd/cjh-39-11-952-g001.jpg

相似文献

[1]
[Safety and efficacy of chimeric antigen receptor T cell in the treatment of elderly patients with hematological malignancies].

Zhonghua Xue Ye Xue Za Zhi. 2018-11-14

[2]
Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis.

BMC Cancer. 2022-1-24

[3]
Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies.

Cancers (Basel). 2022-6-30

[4]
Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies.

Cancer Med. 2023-4

[5]
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies.

Recent Pat Anticancer Drug Discov. 2024

[6]
The Unprecedented Success of Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Hematological Malignancies.

Cureus. 2024-5-9

[7]
Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies.

Stem Cell Res Ther. 2022-9-24

[8]
The Role of Chimeric Antigen Receptor-T Cell Therapy in the Treatment of Hematological Malignancies: Advantages, Trials, and Tribulations, and the Road Ahead.

Cureus. 2021-2-25

[9]
Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies.

Int J Mol Sci. 2023-5-23

[10]
Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies.

Mol Ther. 2024-8-7

本文引用的文献

[1]
Chimeric antigen receptor T-cell therapies for multiple myeloma.

Blood. 2017-12-14

[2]
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

Ann Oncol. 2017-7-1

[3]
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.

Sci Transl Med. 2016-9-7

[4]
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.

J Clin Invest. 2016-6-1

[5]
CD19-Targeted T Cells for Hematologic Malignancies: Clinical Experience to Date.

Cancer J. 2015

[6]
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Lancet Oncol. 2014-10-26

[7]
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

Lancet. 2015-2-7

[8]
Chimeric antigen receptor T cells for sustained remissions in leukemia.

N Engl J Med. 2014-10-16

[9]
Current concepts in the diagnosis and management of cytokine release syndrome.

Blood. 2014-5-29

[10]
Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials.

Leuk Lymphoma. 2012-9-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索